Illumina Inc
Change company Symbol lookup
Select an option...
ILMN Illumina Inc
FRSHY China Jinmao Holdings Group Ltd
EQH-C Equitable Holdings Inc
IBTX Independent Bank Group Inc
DLTR Dollar Tree Inc
FRTX Fresh Tracks Therapeutics Inc
PLXS Plexus Corp
YEXT Yext Inc
UPWK Upwork Inc
NEGG Newegg Commerce Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Blend
Company profile

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Closing Price
$214.03
Day's Change
1.25 (0.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
215.09
Day's Low
207.83
Volume
(Average)
Volume:
1,137,280

10-day average volume:
1,150,542
1,137,280

Illumina To Webcast Upcoming Investor Conferences

4:05 pm ET November 15, 2022 (PR Newswire) Print

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:

-- Evercore ISI HealthCONx Conference on November 29, 2022Fireside Chat at 8:20am Pacific Time (11:20am Eastern Time)

-- Piper Sandler 34th Annual Healthcare Conference on November 30, 2022Fireside Chat at 6:00am Pacific Time (9:00am Eastern Time)

The webcasts can be accessed through the Investor Info section of Illumina's website atinvestor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visitwww.illumina.comand connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

Investors:Salli Schwartz+1.858.291.6421ir@illumina.com

Media:David McAlpine+1.347.327.1336pr@illumina.com

https://c212.net/c/img/favicon.png?sn=LA37581&sd=2022-11-15

View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conferences-301679181.html

SOURCE Illumina, Inc.

https://rt.newswire.ca/rt.gif?NewsItemId=LA37581&Transmission_Id=202211151605PR_NEWS_USPR_____LA37581&DateId=20221115

comtex tracking

COMTEX_418953975/1005/2022-11-15T16:05:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.